May 30 2013
The WorkingBuildings Companies, a leading provider of comprehensive Owner-based solutions for the built environment, is pleased to announce the acquisition of Specialty Operations Solutions (SOS), a national provider of research and laboratory services.
This addition to the firm strengthens The WorkingBuildings Companies' position as one of the fastest-growing comprehensive professional services firm in the world and expands their existing service offerings.
The WorkingBuildings Companies features six specialized divisions of service dedicated to providing facility Owners with quality processes for the built environment. These six divisions include WorkingBuildings, WorkingHospitals, WorkingLaboratories, WB | Global Advisory, CxAlloy, and now, SOS. All branches work to define success for projects and to address inconsistencies when bringing complex facilities online, and SOS specifically adds medical products to market. The services our branches provide result in a facility with fewer operational issues and less expense, both during the design and construction phase and throughout the operational lifespan.
President and CEO of WorkingBuildings, Michael Weiss , says of the acquisition, "SOS fits in seamlessly with the goals of The WorkingBuildings Companies. The addition of this highly respected group of doctors, scientists, engineers, and technicians to the WorkingBuildings team will provide great value to our clients. We will be able to provide owners with a truly turnkey research or manufacturing laboratory that is assured to operate efficiently, to meet all the mandatory requirements, and to achieve FDA compliance. We can now accomplish this while simultaneously reducing the construction and operational cost. Our expanded service offerings give WorkingBuildings greater depth and capabilities while providing consistency typically not found in the marketplace. We are very excited about the possibilities this new addition brings."
With this new division, The WorkingBuildings Companies is able to assist their clients with turnkey services for CGMP laboratory facilities and manufacturing facilities and GTP laboratory and manufacturing facilities for products designed to treat a variety of human and animal diseases and injuries. The SOS staff is particularly experienced with cell and tissue therapies, regenerative medicine products, cord blood banking and processing, USP<797> and USP<823> dispensing facilities, and in the specific facility and process needs required for new and emerging therapies and devices. SOS' services include but are not limited to detailed basis of design document development, facility project management, facility programming, complete quality assurance and regulatory services support, SOP development and training, and research animal care. The SOS division will focus on the GxP, research animal care, and USP<797>/<823> markets to provide Owners with a facility and program that will meet stringent FDA, USDA, EMEA, AAALAC-I and State Pharmacy Control Board requirements.